Biotech Stocks Pop — How to Profit

The emerging biotech sector has seen a lot of attention lately, so you might be wondering how best to get started investing. Research analyst Matt Clark goes over three biotech ETFs and discusses larger trends in this sector.

0:00 — Introduction
0:39 — Recent biotech trends
9:03 — Poll of the week: next state to legalize

About Matt Clark: Matt Clark is a 25-year journalism veteran covering topics from college sports to politics and business. Over the course of his career, he has been awarded investigative journalism, business reporting, editorial writing, and sports coverage. Now, he’s the research analyst for Money & Markets, where he hosts The Bull & The Bear podcast — available on Apple Podcasts, Spotify, and Google Podcasts.

Follow Money & Markets on Social Media!

#Biotech #Stocks #ETF

[InvestingCatalysts]

Matt, I love the work you do and subscribe. But . . . . I question your analysis of the data. Please hear me out.

You preface with diversification. So If you have most of your assets in large index funds and are looking to speculate with some edge case funds, BBH is the WORST choice. Having big players that are already in the SPY index, you aren't diversifying away from your portfolio AND you don't have the skyshot roulette chances of ARKG. Don't buy ark funds as core holdings. Buy them for your edge case home run / strike out plays. Also, BBH is index based, not picked by team. Worth discussing the source of the internal picks in more detail.

Encourage you to look at these industry plays in reference to entire portfolio, not as stand alone.

[scottfabyanic]

Targeted medicine, how about actual wellness and thus limited or no need for medicine? How about taking care (for real) of your DNA. Barry Sears already lead the charge...way in front. Dont want new genes thats natures job. I want to control the expression (based on natures interaction with genes over the evolutionary process) and the best way to do that is through specific nutrients and macro contenr. You have to Resolve inflammation (resolvins) and Repair (initiate AMPK) tissue. The process is termed "Zone Pro-Resolution Nutrition™" and drugs simply cant achieve the results. Even if the biotech treatments have nutritional constituents the high grade supplements required already exist and are highly effective. I realize people are more interested in money on this thread however, its amazing how we jump passed the reason why. Inflammation wont resolve without adequate EPA/DHA concentrates and AMPK is mainly triggered by water soluble polyphenols like delphinidins. If not you will need more and more "targeted" to treat/pervert downstream enzymes, etc. But hey there is no big money to be made in contentment.